Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers.
Nostrum Biodiscovery provides advanced technologies in Molecular Modelling, with two areas of focus : Therapeutics (small molecules design, TPDs, antibodies, immunologics, nucleic acids) and Bio-based Chemistry (enzyme engineering/ab initio creatio)..
Nostrum Biodiscovery's customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. Nostrum Biodiscovery uses best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms.
Nostrum Biodiscovery is also developing its own portfolio of small molecules and enzymes.
Nostrum Biodiscovery's competitive advantage not only relies on its software and IT capacity, but also on its expertise, with talented and passionate people with backgrounds in Med Chem, Biophysics, IT and Business.
Nostrum Biodiscovery has clients in more than 12 countries and is currently expanding in Asia, Latin America while strengthening its presence in the US and Europe.